text.skipToContent text.skipToNavigation
Need help? Please contact us

X-VIVOTM 15 Serum-free Hematopoietic Cell Medium

X-VIVOTM 15 Serum-free Hematopoietic Cell Medium

Catalog #: 04-418Q

X-VIVOTM 15, Serum free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree 1 L

 

Want to request a quote or find our more information about this product including customization options?  Please fill in your request and your local sales specialist will contact you.    

 

Do you need a quote right away? Add this product to your shopping cart, go to your cart and click on “Generate Quote”. Your quote will be available straight away to view, save online, and download in PDF format.

Compare

Select Size

204.00 USD
BOT

Product Overview

X-VIVOTM 15 Media are similar in composition to X-VIVOTM 10 Media and have been optimized for the proliferation of tumor infiltrating lymphocytes (TIL) under serum-free conditions. X-VIVOTM 15 Media support the proliferation of purified CD3+ cells isolated from peripheral blood and human tumors. X-VIVOTM 15 Media can also be used to support the growth of human monocytes, macrophage cells and cell lines, PBL, granulocytes, and natural killer (NK) cells. In addition, X-VIVOTM 15 Media provide a serum-free environment for the expansion of HUT-78 and related human lymphocytic cell lines.

All BioWhittakerTM Cell Culture Media products are for Research Use Only (RUO) and are not approved for human or veterinary use or for use in clinical or in vitro diagnostic procedures. If you require GMP grade media, contact Lonza for more details.

 

Request More Info

Benefits

  • Superior media for most hematopoietic cells types including dendritic cells, lymphocytes, monocytes, macrophages and granulocytes.
  • Formulations only contain human derived components
  • Highly cited in scientific literature
  • Clinical proven formulations providing process safety and constancy
  • High productivity resulting in a high viable cell yield
  • Serum Free media result in a more defined process and result in limited immune response
  • Efficient transgene expression
  • Desirable T-cell phenotype

Applications

  • Proliferation of peripheral blood lymphocytes
  • Proliferation of tumor infiltrating lymphocytes 
  • Cryopreservation of human tissue
  • Cultivation of human monocytes and macrophages
  • Cultivation of stem cells
  • Cultivation of dendritic cells
  • Cultiviation of CAR-T cells

Storage and Content

1L bottle
Return to Top

SDS, CoA, and Instructions

Safety Data Sheets (SDS)

Choose a language to view the SDS.

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

  • References - X-Vivo™

    Overview of relevant references
  • Protocols for converting cells to serum-free culture

    Procedures how to get away from serum.
  • TechSheet - X-VIVO™ Media Systems

    Instructions for how to use the X-VIVO™ Media Series
  • B-ALI Immune-Airway Co-Culture Model: Normal Human Bronchial Epithelial cells and Peripheral Blood Mononuclear Cells - Instructions for use

    Protocol to culture B-ALI NHBE cells with PBMCs
Return to Top

Educational Material

Brochures, White Papers etc.

  • Developing Patient-specific Cell Therapy Manufacturing Processes

    Poster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.
  • CAR T cells in Cancer Therapy

    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • A Non-Viral Method for Modifying and Expanding Primary T Cells

    Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • PBMC Based T Cell Proliferation Assay

    Protocol instructions
Return to Top